首页> 外文OA文献 >Sensitive spectrophotometric determination of lansoprazole in pharmaceuticals using ceric ammonium sulphate based on redox and complex formation reactions.
【2h】

Sensitive spectrophotometric determination of lansoprazole in pharmaceuticals using ceric ammonium sulphate based on redox and complex formation reactions.

机译:基于氧化还原和络合物形成反应的硫酸铈铈分光光度法测定药物中的兰索拉唑。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two simple sensitive and cost-effective spectrophotometric methods are described for the detn. of lansoprazole (LPZ) in bulk drug and in capsules using ceric ammonium sulfate (CAS), iron(II), orthophenanthroline and thiocyanate as reagents. In both methods, an acidic soln. of lansoprazole is treated with a measured excess of CAS followed by the detn. of unreacted oxidant by 2 procedures involving different reaction schemes. The 1st method involves the redn. of residual oxidant by a known amt. of iron(II), and the unreacted iron(II) is complexed with orthophenanthroline at a raised pH, and the absorbance of the resulting complex measured at 510 nm (method A). In the 2nd method, the unreacted CAS is reduced by excess of iron(II), and the resulting iron(III) is complexed with thiocyanate in the acid medium and the absorbance of the complex measured at 470 nm (method B). In both methods, the amt. CAS reacted corresponds to the amt. of LPZ. In method A, the absorbance is found to increase linearly with the concn. of LPZ where as in method B a linear decrease in absorbance occurs. The systems obey Beer's law for 2.5-30 and 2.5-25 μg mL-1 for method A and method B, resp., and the corresponding molar absorptivity values are 8.1 × 103 and 1.5 × 104 L mol-1cm-1. The methods were successfully applied to the detn. of LPZ in capsules and the results tallied well with the label claim. No interference was obsd. from the concomitant substances normally added to capsules. [on SciFinder(R)]
机译:描述了两种简单的灵敏且具有成本效益的分光光度法。硫酸铈铵(CAS),铁(II),邻菲咯啉和硫氰酸盐为试剂的散装药物和胶囊中的兰索拉唑(LPZ)的制备。在两种方法中,都是酸性溶液。用一定量的过量CAS处理兰索拉唑,然后进行detn处理。通过涉及不同反应方案的2种方法制备未反应的氧化剂第一种方法涉及重做。已知氧化剂清除残留氧化剂。然后,在升高的pH值下,将未反应的铁(II)与邻菲咯啉络合,并在510 nm下测量所得络合物的吸光度(方法A)。在第二种方法中,未反应的CAS通过过量的铁(II)还原,所得铁(III)在酸性介质中与硫氰酸盐络合,并在470 nm下测量该络合物的吸光度(方法B)。在这两种方法中,amt。反应的CAS对应于amt。 LPZ。在方法A中,发现吸光度随浓度线性增加。与方法B中一样,LPZ的吸光度会线性下降。该系统遵守方法A和方法B分别为2.5-30和2.5-25μgmL-1的比尔定律,相应的摩尔吸光度值为8.1×103和1.5×104 L mol-1cm-1。该方法已成功应用于检测。胶囊中LPZ的含量,结果与标签要求相符。没有干扰。从通常添加到胶囊的伴随物质中提取。 [在SciFinder(R)上]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号